Skip to main content
Stonvex
Loading…
Home
Activity
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search…
⌘K
Search…
⌘K
Log in
Get Started
← Back to rankings
ELDN
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Loading latest news…
52w high -17.4%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
eledon
pharmaceuticals
kidney
nasdaq
tegoprubart
transplant
trading
high
last
compared
results
trial
conference
phase
rating
2023
period
2022
transplantation
rejection
ELDN
Eledon Pharmaceuticals, Inc. Common Stock
Stonvex
StonvexStonvexStonvexStonvex